Variant report
Variant | nsv970082 |
---|---|
Chromosome Location | chr6:26122853-26124775 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:949)
- CpG islands (count:855)
- Chromatin interactive region (count:136)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr6:26122827-26124601 | K562 | blood: | n/a | chr6:26124490-26124502 |
2 | ARID3A | chr6:26123984-26124819 | HepG2 | liver: | n/a | chr6:26124490-26124502 |
3 | ARID3A | chr6:26122838-26123621 | HepG2 | liver: | n/a | n/a |
4 | ATF1 | chr6:26122682-26123583 | K562 | blood: | n/a | n/a |
5 | ATF1 | chr6:26123979-26124531 | K562 | blood: | n/a | n/a |
6 | ATF2 | chr6:26122582-26127052 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | ATF2 | chr6:26122847-26125185 | GM12878 | blood: | n/a | n/a |
8 | ATF2 | chr6:26122839-26124768 | GM12878 | blood: | n/a | n/a |
9 | ATF2 | chr6:26122590-26125042 | H1-hESC | embryonic stem cell: | n/a | n/a |
10 | ATF3 | chr6:26122579-26123726 | K562 | blood: | n/a | n/a |
11 | ATF3 | chr6:26122980-26124669 | A549 | lung: | n/a | n/a |
12 | ATF3 | chr6:26123841-26124580 | A549 | lung: | n/a | n/a |
13 | BACH1 | chr6:26122349-26123653 | K562 | blood: | n/a | n/a |
14 | BATF | chr6:26123066-26123465 | GM12878 | blood: | n/a | n/a |
15 | BATF | chr6:26123656-26124189 | GM12878 | blood: | n/a | n/a |
16 | BCL11A | chr6:26123663-26124225 | GM12878 | blood: | n/a | n/a |
17 | BCL11A | chr6:26123719-26124090 | GM12878 | blood: | n/a | n/a |
18 | BCL11A | chr6:26123161-26123642 | GM12878 | blood: | n/a | n/a |
19 | BCL3 | chr6:26122868-26124718 | A549 | lung: | n/a | n/a |
20 | BCL3 | chr6:26123015-26123652 | K562 | blood: | n/a | n/a |
21 | BCL3 | chr6:26122988-26124972 | A549 | lung: | n/a | n/a |
22 | BCLAF1 | chr6:26120463-26129092 | K562 | blood: | n/a | chr6:26126779-26126788 chr6:26122722-26122731 chr6:26125896-26125905 |
23 | BCLAF1 | chr6:26122252-26127868 | K562 | blood: | n/a | chr6:26126779-26126788 chr6:26122722-26122731 chr6:26125896-26125905 |
24 | BCLAF1 | chr6:26123036-26125536 | GM12878 | blood: | n/a | n/a |
25 | BCLAF1 | chr6:26122860-26125297 | GM12878 | blood: | n/a | n/a |
26 | BHLHE40 | chr6:26122706-26123528 | K562 | blood: | n/a | n/a |
27 | BHLHE40 | chr6:26123937-26124926 | K562 | blood: | n/a | n/a |
28 | BHLHE40 | chr6:26122850-26124589 | GM12878 | blood: | n/a | n/a |
29 | BRCA1 | chr6:26123055-26123731 | Hela-S3 | cervix: | n/a | n/a |
30 | BRCA1 | chr6:26123900-26124685 | GM12878 | blood: | n/a | n/a |
31 | BRCA1 | chr6:26123959-26124845 | HepG2 | liver: | n/a | n/a |
32 | BRCA1 | chr6:26123962-26124660 | Hela-S3 | cervix: | n/a | n/a |
33 | BRCA1 | chr6:26123099-26123617 | HepG2 | liver: | n/a | n/a |
34 | CBX3 | chr6:26123810-26124658 | K562 | blood: | n/a | n/a |
35 | CBX3 | chr6:26123039-26123609 | K562 | blood: | n/a | n/a |
36 | CBX3 | chr6:26122602-26124928 | K562 | blood: | n/a | n/a |
37 | CBX3 | chr6:26122638-26124771 | HCT-116 | colon: | n/a | n/a |
38 | CCNT2 | chr6:26123188-26124802 | K562 | blood: | n/a | n/a |
39 | CEBPB | chr6:26122889-26123573 | HepG2 | liver: | n/a | n/a |
40 | CEBPB | chr6:26123012-26123668 | MCF-7 | breast: | n/a | n/a |
41 | CEBPB | chr6:26123842-26124642 | K562 | blood: | n/a | n/a |
42 | CEBPB | chr6:26123932-26124573 | GM12878 | blood: | n/a | n/a |
43 | CEBPB | chr6:26122934-26123704 | A549 | lung: | n/a | n/a |
44 | CEBPB | chr6:26123045-26123517 | HepG2 | liver: | n/a | n/a |
45 | CEBPB | chr6:26124044-26124619 | HepG2 | liver: | n/a | n/a |
46 | CEBPB | chr6:26123883-26124699 | A549 | lung: | n/a | n/a |
47 | CEBPB | chr6:26123142-26123460 | K562 | blood: | n/a | n/a |
48 | CEBPB | chr6:26122908-26123706 | ECC-1 | luminal epithelium: | n/a | n/a |
49 | CEBPB | chr6:26124262-26124600 | ECC-1 | luminal epithelium: | n/a | n/a |
50 | CEBPB | chr6:26123147-26123561 | GM12878 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:26124504-26124554 | HMEC | breast: | n/a |
2 | chr6:26124504-26124554 | HMEC | breast: | n/a |
3 | chr6:26124417-26124467 | AoSMC | blood vessel: | n/a |
4 | chr6:26123398-26123448 | HNPCEpiC | eye: | n/a |
5 | chr6:26123398-26123448 | ProgFib | skin: | n/a |
6 | chr6:26123398-26123448 | AG04450 | lung: | fetal |
7 | chr6:26124345-26124395 | AG09309 | skin: | n/a |
8 | chr6:26123468-26123518 | LNCaP | prostate: | n/a |
9 | chr6:26124704-26124754 | NHDF-neo | bronchial: | n/a |
10 | chr6:26123458-26123508 | HCPEpiC | choroid plexus: | n/a |
11 | chr6:26124329-26124379 | SAEC | small airway: | n/a |
12 | chr6:26124504-26124554 | Jurkat | blood: | n/a |
13 | chr6:26124601-26124651 | HEK293 | kidney: | embryo |
14 | chr6:26124167-26124217 | HCF | heart: | n/a |
15 | chr6:26123398-26123448 | PrEC | prostate: | n/a |
16 | chr6:26124167-26124217 | HUVEC | blood vessel: | n/a |
17 | chr6:26124504-26124554 | PFSK-1 | brain: | n/a |
18 | chr6:26123228-26123278 | Jurkat | blood: | n/a |
19 | chr6:26124417-26124467 | PrEC | prostate: | n/a |
20 | chr6:26123736-26123786 | Caco-2 | colon: | n/a |
21 | chr6:26124167-26124217 | PFSK-1 | brain: | n/a |
22 | chr6:26124704-26124754 | U87 | brain: | n/a |
23 | chr6:26123398-26123448 | HL-60 | blood: | n/a |
24 | chr6:26124329-26124379 | AG04449 | skin: | fetal |
25 | chr6:26123736-26123786 | SKMC | muscle: | n/a |
26 | chr6:26124345-26124395 | SK-N-SH_RA | brain: | n/a |
27 | chr6:26124704-26124754 | HCPEpiC | choroid plexus: | n/a |
28 | chr6:26123458-26123508 | AG04450 | lung: | fetal |
29 | chr6:26123228-26123278 | BJ | skin: | n/a |
30 | chr6:26123228-26123278 | HCPEpiC | choroid plexus: | n/a |
31 | chr6:26124417-26124467 | BJ | skin: | n/a |
32 | chr6:26124704-26124754 | MCF10A-Er-Src | breast: | n/a |
33 | chr6:26124504-26124554 | ovcar-3 | ovarian: | n/a |
34 | chr6:26123228-26123278 | Hela-S3 | cervix: | n/a |
35 | chr6:26124704-26124754 | HUVEC | blood vessel: | n/a |
36 | chr6:26124345-26124395 | H1-hESC | embryonic stem cell: | embryo |
37 | chr6:26123915-26123965 | CMK | blood: | n/a |
38 | chr6:26123398-26123448 | K562 | blood: | n/a |
39 | chr6:26123228-26123278 | HCM | heart: | n/a |
40 | chr6:26124345-26124395 | SKMC | muscle: | n/a |
41 | chr6:26124601-26124651 | BJ | skin: | n/a |
42 | chr6:26123281-26123331 | MCF10A-Er-Src | breast: | n/a |
43 | chr6:26124329-26124379 | GM12878 | blood: | n/a |
44 | chr6:26124329-26124379 | BE2_C | brain: | n/a |
45 | chr6:26123228-26123278 | NHDF-neo | bronchial: | n/a |
46 | chr6:26123736-26123786 | HL-60 | blood: | n/a |
47 | chr6:26123915-26123965 | AG04449 | skin: | fetal |
48 | chr6:26124329-26124379 | A549 | lung: | n/a |
49 | chr6:26124504-26124554 | LNCaP | prostate: | n/a |
50 | chr6:26124167-26124217 | HMEC | breast: | n/a |
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr15:72497728..72499574-chr6:26124420..26126089,2 | MCF-7 | breast: | |
2 | chr6:26119863..26128842-chr6:27096583..27102911,26 | K562 | blood: | |
3 | chr6:26123837..26124686-chr6:26157659..26158968,4 | HCT-116 | colon: | |
4 | chr12:57039309..57039864-chr6:26123722..26124692,2 | Hela-S3 | cervix: | |
5 | chr6:26122958..26124980-chr6:26596151..26598779,2 | K562 | blood: | |
6 | chr6:26122455..26127911-chr6:27777953..27784057,9 | MCF-7 | breast: | |
7 | chr6:26033491..26034015-chr6:26123741..26124703,2 | Hela-S3 | cervix: | |
8 | chr6:26123945..26125914-chr6:26596676..26599538,2 | MCF-7 | breast: | |
9 | chr12:120728750..120731151-chr6:26122408..26123932,2 | MCF-7 | breast: | |
10 | chr5:131826235..131826994-chr6:26123977..26124876,2 | Hela-S3 | cervix: | |
11 | chr18:12947366..12948044-chr6:26124586..26125548,2 | Hela-S3 | cervix: | |
12 | chr6:26124305..26124938-chr8:8243493..8244064,2 | HCT-116 | colon: | |
13 | chr6:26123030..26125902-chr6:43596197..43598977,2 | MCF-7 | breast: | |
14 | chr6:26122193..26124669-chr6:27781205..27782892,3 | MCF-7 | breast: | |
15 | chr15:97279669..97280667-chr6:26124490..26125013,2 | MCF-7 | breast: | |
16 | chr3:160116717..160117703-chr6:26124014..26125025,3 | Hela-S3 | cervix: | |
17 | chr17:77768640..77771440-chr6:26122363..26124849,2 | MCF-7 | breast: | |
18 | chr6:26122811..26125684-chr6:26519933..26522732,4 | K562 | blood: | |
19 | chr21:44395301..44396096-chr6:26123159..26123981,2 | Hela-S3 | cervix: | |
20 | chr11:17297568..17298688-chr6:26123742..26124744,3 | Hela-S3 | cervix: | |
21 | chr6:26123627..26125056-chr6:26157699..26158576,4 | Hela-S3 | cervix: | |
22 | chr6:26122616..26125832-chr6:27791584..27793805,3 | K562 | blood: | |
23 | chr6:26123115..26123621-chr6:26157745..26158457,2 | HCT-116 | colon: | |
24 | chr1:149223816..149224352-chr6:26123704..26124591,2 | Hela-S3 | cervix: | |
25 | chr6:26124249..26127079-chr6:27774998..27777814,2 | MCF-7 | breast: | |
26 | chr11:65273507..65275023-chr6:26121224..26123950,2 | K562 | blood: | |
27 | chr14:100705400..100707404-chr6:26123077..26125052,2 | MCF-7 | breast: | |
28 | chr1:149857091..149860702-chr6:26123340..26126187,3 | MCF-7 | breast: | |
29 | chr19:16652794..16653665-chr6:26123619..26124196,2 | Hela-S3 | cervix: | |
30 | chr16:68589688..68592396-chr6:26122014..26124256,2 | MCF-7 | breast: | |
31 | chr6:26123935..26124617-chrX:69509644..69510498,2 | Hela-S3 | cervix: | |
32 | chr1:853931..856042-chr6:26122746..26124318,2 | MCF-7 | breast: | |
33 | chr19:16682796..16683592-chr6:26123802..26124536,2 | Hela-S3 | cervix: | |
34 | chr6:25726943..25728808-chr6:26121898..26123990,2 | K562 | blood: | |
35 | chr14:92301896..92304866-chr6:26122642..26125225,2 | MCF-7 | breast: | |
36 | chr17:62222981..62223792-chr6:26124304..26124897,2 | Hela-S3 | cervix: | |
37 | chr6:26123260..26124210-chr6:33175981..33176679,2 | HCT-116 | colon: | |
38 | chr20:47894862..47895418-chr6:26123808..26124481,2 | Hela-S3 | cervix: | |
39 | chr5:176943515..176944451-chr6:26124410..26125053,2 | Hela-S3 | cervix: | |
40 | chr5:40678741..40679756-chr6:26123548..26124204,3 | Hela-S3 | cervix: | |
41 | chr6:26123490..26124560-chr6:27099440..27100635,4 | Hela-S3 | cervix: | |
42 | chr6:26124476..26125172-chr7:4815282..4816227,2 | Hela-S3 | cervix: | |
43 | chr13:42614178..42615159-chr6:26123039..26124034,3 | Hela-S3 | cervix: | |
44 | chr19:17354916..17355830-chr6:26123340..26124086,2 | Hela-S3 | cervix: | |
45 | chr1:161719167..161719902-chr6:26124018..26124853,2 | Hela-S3 | cervix: | |
46 | chr6:26120836..26126141-chr6:27110374..27116911,13 | K562 | blood: | |
47 | chr19:49138216..49138781-chr6:26123309..26123814,2 | NB4 | blood: | |
48 | chr17:57913398..57916959-chr6:26122368..26124244,3 | MCF-7 | breast: | |
49 | chr5:138940231..138940758-chr6:26124166..26124760,2 | Hela-S3 | cervix: | |
50 | chr3:156877450..156878143-chr6:26124036..26124672,2 | Hela-S3 | cervix: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
HIST1H2AC | TF binding region |
HIST1H2BC | TF binding region |
HIST1H2AC | CpG island |
HIST1H2BC | CpG island |
ENSG00000137259 | chromatin interactions |
ENSG00000184939 | chromatin interactions |
ENSG00000070081 | chromatin interactions |
ENSG00000141570 | chromatin interactions |
ENSG00000103047 | chromatin interactions |
ENSG00000184270 | chromatin interactions |
ENSG00000196532 | chromatin interactions |
ENSG00000258458 | chromatin interactions |
ENSG00000173486 | chromatin interactions |
ENSG00000068885 | chromatin interactions |
ENSG00000163435 | chromatin interactions |
ENSG00000129667 | chromatin interactions |
ENSG00000067225 | chromatin interactions |
ENSG00000182944 | chromatin interactions |
ENSG00000158373 | chromatin interactions |
ENSG00000078043 | chromatin interactions |
ENSG00000146047 | chromatin interactions |
ENSG00000075426 | chromatin interactions |
ENSG00000213722 | chromatin interactions |
ENSG00000196226 | chromatin interactions |
ENSG00000177410 | chromatin interactions |
ENSG00000184357 | chromatin interactions |
ENSG00000250588 | chromatin interactions |
ENSG00000266402 | chromatin interactions |
ENSG00000196374 | chromatin interactions |
ENSG00000245534 | chromatin interactions |
ENSG00000225721 | chromatin interactions |
ENSG00000173540 | chromatin interactions |
ENSG00000199753 | chromatin interactions |
ENSG00000232536 | chromatin interactions |
ENSG00000124529 | chromatin interactions |
ENSG00000138772 | chromatin interactions |
ENSG00000102977 | chromatin interactions |
ENSG00000164040 | chromatin interactions |
ENSG00000101181 | chromatin interactions |
ENSG00000141543 | chromatin interactions |
ENSG00000234816 | chromatin interactions |
ENSG00000167658 | chromatin interactions |
ENSG00000146109 | chromatin interactions |
ENSG00000197061 | chromatin interactions |
ENSG00000197956 | chromatin interactions |
ENSG00000100445 | chromatin interactions |
ENSG00000124693 | chromatin interactions |
ENSG00000155463 | chromatin interactions |
ENSG00000189223 | chromatin interactions |
ENSG00000090889 | chromatin interactions |
ENSG00000143751 | chromatin interactions |
ENSG00000125347 | chromatin interactions |
ENSG00000124659 | chromatin interactions |
ENSG00000265855 | chromatin interactions |
ENSG00000185130 | chromatin interactions |
ENSG00000187049 | chromatin interactions |
ENSG00000137502 | chromatin interactions |
ENSG00000130340 | chromatin interactions |
ENSG00000197238 | chromatin interactions |
ENSG00000131508 | chromatin interactions |
ENSG00000100811 | chromatin interactions |
ENSG00000085872 | chromatin interactions |
ENSG00000197846 | chromatin interactions |
ENSG00000142937 | chromatin interactions |
ENSG00000198366 | chromatin interactions |
ENSG00000187837 | chromatin interactions |
ENSG00000181817 | chromatin interactions |
ENSG00000132394 | chromatin interactions |
ENSG00000138468 | chromatin interactions |
ENSG00000158406 | chromatin interactions |
ENSG00000202538 | chromatin interactions |
ENSG00000085491 | chromatin interactions |
ENSG00000109736 | chromatin interactions |
ENSG00000197914 | chromatin interactions |
ENSG00000265565 | chromatin interactions |
ENSG00000128915 | chromatin interactions |
ENSG00000127526 | chromatin interactions |
ENSG00000181163 | chromatin interactions |
ENSG00000223764 | chromatin interactions |
ENSG00000234678 | chromatin interactions |
ENSG00000120509 | chromatin interactions |
ENSG00000167216 | chromatin interactions |
ENSG00000233224 | chromatin interactions |
ENSG00000205189 | chromatin interactions |
ENSG00000006652 | chromatin interactions |
ENSG00000163882 | chromatin interactions |
ENSG00000062716 | chromatin interactions |
ENSG00000183258 | chromatin interactions |
ENSG00000182611 | chromatin interactions |
ENSG00000204569 | chromatin interactions |
ENSG00000142632 | chromatin interactions |
ENSG00000181019 | chromatin interactions |
ENSG00000197409 | chromatin interactions |
ENSG00000182319 | chromatin interactions |
ENSG00000184678 | chromatin interactions |
ENSG00000163660 | chromatin interactions |
ENSG00000110955 | chromatin interactions |
ENSG00000140988 | chromatin interactions |
ENSG00000060749 | chromatin interactions |
ENSG00000100263 | chromatin interactions |
ENSG00000197153 | chromatin interactions |
ENSG00000182768 | chromatin interactions |
ENSG00000196787 | chromatin interactions |
ENSG00000065150 | chromatin interactions |
ENSG00000228223 | chromatin interactions |
ENSG00000187990 | chromatin interactions |
ENSG00000264294 | chromatin interactions |
ENSG00000233822 | chromatin interactions |
ENSG00000124201 | chromatin interactions |
ENSG00000249673 | chromatin interactions |
ENSG00000124635 | chromatin interactions |
ENSG00000184825 | chromatin interactions |
ENSG00000184260 | chromatin interactions |
ENSG00000242802 | chromatin interactions |
ENSG00000200913 | chromatin interactions |
ENSG00000263002 | chromatin interactions |
ENSG00000196176 | chromatin interactions |
ENSG00000198408 | chromatin interactions |
ENSG00000196747 | chromatin interactions |
ENSG00000198558 | chromatin interactions |
ENSG00000124610 | chromatin interactions |
ENSG00000204227 | chromatin interactions |
ENSG00000108854 | chromatin interactions |
ENSG00000081721 | chromatin interactions |
ENSG00000172432 | chromatin interactions |
ENSG00000137601 | chromatin interactions |
ENSG00000197903 | chromatin interactions |
ENSG00000172115 | chromatin interactions |
ENSG00000105220 | chromatin interactions |
ENSG00000090054 | chromatin interactions |
ENSG00000178096 | chromatin interactions |
ENSG00000168274 | chromatin interactions |
ENSG00000196866 | chromatin interactions |
ENSG00000182572 | chromatin interactions |
ENSG00000160113 | chromatin interactions |
ENSG00000165929 | chromatin interactions |
ENSG00000124688 | chromatin interactions |
ENSG00000200795 | chromatin interactions |
ENSG00000143367 | chromatin interactions |
ENSG00000246067 | chromatin interactions |
ENSG00000125450 | chromatin interactions |
ENSG00000164508 | chromatin interactions |
ENSG00000172239 | chromatin interactions |
ENSG00000125618 | chromatin interactions |
ENSG00000104472 | chromatin interactions |
ENSG00000171522 | chromatin interactions |
ENSG00000175792 | chromatin interactions |
ENSG00000113810 | chromatin interactions |
ENSG00000119392 | chromatin interactions |
ENSG00000199289 | chromatin interactions |
ENSG00000085415 | chromatin interactions |
ENSG00000206737 | chromatin interactions |
ENSG00000156860 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs553829211 | chr6:26122871-26122872 | Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 36 gene(s) | Overlapped CNVs | n/a |
2 | rs371897392 | chr6:26122875-26122876 | Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 36 gene(s) | Overlapped CNVs | n/a |
3 | rs577406287 | chr6:26122912-26122913 | Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 38 gene(s) | Overlapped CNVs | n/a |
4 | rs540011248 | chr6:26122921-26122922 | Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 38 gene(s) | Overlapped CNVs | n/a |
5 | rs556926819 | chr6:26122927-26122928 | Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 38 gene(s) | Overlapped CNVs | n/a |
6 | rs198823 | chr6:26122933-26122934 | Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 38 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs13200797 | chr6:26122957-26122958 | Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 38 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs562019399 | chr6:26123032-26123033 | Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 43 gene(s) | Overlapped CNVs | n/a |
9 | rs572503887 | chr6:26123086-26123087 | Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 48 gene(s) | Overlapped CNVs | n/a |
10 | rs541210402 | chr6:26123092-26123093 | Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 48 gene(s) | Overlapped CNVs | n/a |
11 | rs530910509 | chr6:26123109-26123110 | Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 48 gene(s) | Overlapped CNVs | n/a |
12 | rs192513001 | chr6:26123144-26123145 | Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 49 gene(s) | Overlapped CNVs | n/a |
13 | rs532240642 | chr6:26123147-26123148 | Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 49 gene(s) | Overlapped CNVs | n/a |
14 | rs140016006 | chr6:26123171-26123172 | Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 49 gene(s) | Overlapped CNVs | n/a |
15 | rs373830897 | chr6:26123179-26123180 | Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 49 gene(s) | Overlapped CNVs | n/a |
16 | rs143499056 | chr6:26123192-26123193 | Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 49 gene(s) | Overlapped CNVs | n/a |
17 | rs77919048 | chr6:26123208-26123209 | Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 49 gene(s) | Overlapped CNVs | n/a |
18 | rs112804686 | chr6:26123218-26123219 | Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 49 gene(s) | Overlapped CNVs | n/a |
19 | rs547786423 | chr6:26123230-26123231 | Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive region | 49 gene(s) | Overlapped CNVs | n/a |
20 | rs185079171 | chr6:26123267-26123268 | Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive region | 51 gene(s) | Overlapped CNVs | n/a |
21 | rs151214127 | chr6:26123291-26123292 | Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive region | 52 gene(s) | Overlapped CNVs | n/a |
22 | rs111229486 | chr6:26123299-26123300 | Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive region | 52 gene(s) | Overlapped CNVs | n/a |
23 | rs570507586 | chr6:26123313-26123314 | Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive region | 52 gene(s) | Overlapped CNVs | n/a |
24 | rs370170580 | chr6:26123353-26123354 | Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 57 gene(s) | Overlapped CNVs | n/a |
25 | rs556762893 | chr6:26123383-26123384 | Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 57 gene(s) | Overlapped CNVs | n/a |
26 | rs576820281 | chr6:26123396-26123397 | Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 58 gene(s) | Overlapped CNVs | n/a |
27 | rs536106943 | chr6:26123410-26123411 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive region | 61 gene(s) | Overlapped CNVs | n/a |
28 | rs556090270 | chr6:26123429-26123430 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive region | 63 gene(s) | Overlapped CNVs | n/a |
29 | rs572386413 | chr6:26123467-26123468 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive region | 66 gene(s) | Overlapped CNVs | n/a |
30 | rs189927783 | chr6:26123474-26123475 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive region | 67 gene(s) | Overlapped CNVs | n/a |
31 | rs372638594 | chr6:26123476-26123477 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive region | 67 gene(s) | Overlapped CNVs | n/a |
32 | rs564451499 | chr6:26123482-26123483 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive region | 67 gene(s) | Overlapped CNVs | n/a |
33 | rs115740542 | chr6:26123502-26123503 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive region | 67 gene(s) | Overlapped CNVs | mRNA abundance |
34 | rs545608798 | chr6:26123505-26123506 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive region | 67 gene(s) | Overlapped CNVs | n/a |
35 | rs532539925 | chr6:26123517-26123518 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive region | 68 gene(s) | Overlapped CNVs | n/a |
36 | rs198822 | chr6:26123539-26123540 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS | TF binding regionChromatin interactive region | 71 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs566810063 | chr6:26123543-26123544 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS | TF binding regionChromatin interactive region | 71 gene(s) | Overlapped CNVs | n/a |
38 | rs59995466 | chr6:26123547-26123548 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS | TF binding regionChromatin interactive region | 71 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs548119883 | chr6:26123558-26123559 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS | TF binding regionChromatin interactive region | 73 gene(s) | Overlapped CNVs | n/a |
40 | rs561633884 | chr6:26123594-26123595 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS | TF binding regionChromatin interactive region | 73 gene(s) | Overlapped CNVs | n/a |
41 | rs527319274 | chr6:26123601-26123602 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionChromatin interactive region | 73 gene(s) | Overlapped CNVs | n/a |
42 | rs547345212 | chr6:26123612-26123613 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionChromatin interactive region | 73 gene(s) | Overlapped CNVs | n/a |
43 | rs570471579 | chr6:26123621-26123622 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionChromatin interactive region | 75 gene(s) | Overlapped CNVs | n/a |
44 | rs539481947 | chr6:26123626-26123627 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionChromatin interactive region | 74 gene(s) | Overlapped CNVs | n/a |
45 | rs198821 | chr6:26123629-26123630 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionChromatin interactive region | 76 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
46 | rs116104991 | chr6:26123632-26123633 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionChromatin interactive region | 76 gene(s) | Overlapped CNVs | n/a |
47 | rs549225831 | chr6:26123648-26123649 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionChromatin interactive region | 76 gene(s) | Overlapped CNVs | n/a |
48 | rs28365923 | chr6:26123649-26123650 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionChromatin interactive region | 76 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs537609928 | chr6:26123650-26123651 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionChromatin interactive region | 76 gene(s) | Overlapped CNVs | n/a |
50 | rs189531424 | chr6:26123656-26123657 | Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionChromatin interactive region | 76 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 22495309 | CNVD |
Lung cancer | 21569311 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 20808228 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:26119600-26123400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr6:26121600-26123200 | Flanking Active TSS | Liver | Liver |
3 | chr6:26121800-26125400 | Active TSS | K562 | blood |
4 | chr6:26122400-26123000 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
5 | chr6:26122400-26123000 | Flanking Active TSS | A549 | lung |
6 | chr6:26122400-26123000 | Flanking Active TSS | HMEC | breast |
7 | chr6:26122400-26123200 | Flanking Active TSS | HUES48 Cell Line | embryonic stem cell |
8 | chr6:26122400-26123200 | Flanking Active TSS | HUES6 Cell Line | embryonic stem cell |
9 | chr6:26122400-26123200 | Flanking Active TSS | HUES64 Cell Line | embryonic stem cell |
10 | chr6:26122400-26123200 | Flanking Active TSS | Dnd41 | blood |
11 | chr6:26122400-26123200 | Flanking Active TSS | Hela-S3 | cervix |
12 | chr6:26122400-26123200 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
13 | chr6:26122400-26123400 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
14 | chr6:26122400-26123400 | Flanking Active TSS | Fetal Thymus | thymus |
15 | chr6:26122400-26127800 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
16 | chr6:26122600-26123000 | Flanking Active TSS | H1 Cell Line | embryonic stem cell |
17 | chr6:26122600-26123000 | Flanking Active TSS | H9 Derived Neuron Cultured Cells | ES cell derived |
18 | chr6:26122600-26123000 | Flanking Active TSS | Primary T cells from cord blood | blood |
19 | chr6:26122600-26123000 | Flanking Active TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
20 | chr6:26122600-26123000 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
21 | chr6:26122600-26123000 | Flanking Active TSS | Brain Anterior Caudate | brain |
22 | chr6:26122600-26123000 | Flanking Active TSS | Colon Smooth Muscle | Colon |
23 | chr6:26122600-26123000 | Flanking Active TSS | Fetal Intestine Small | intestine |
24 | chr6:26122600-26123000 | Flanking Active TSS | Rectal Mucosa Donor 29 | rectum |
25 | chr6:26122600-26123000 | Flanking Active TSS | Rectal Mucosa Donor 31 | rectum |
26 | chr6:26122600-26123000 | Flanking Active TSS | Stomach Smooth Muscle | stomach |
27 | chr6:26122600-26123000 | Flanking Active TSS | Thymus | Thymus |
28 | chr6:26122600-26123200 | Flanking Active TSS | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
29 | chr6:26122600-26123200 | Flanking Active TSS | iPS-15b Cell Line | embryonic stem cell |
30 | chr6:26122600-26123200 | Flanking Active TSS | iPS-18 Cell Line | embryonic stem cell |
31 | chr6:26122600-26123200 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |
32 | chr6:26122600-26123200 | Flanking Active TSS | Primary B cells from cord blood | blood |
33 | chr6:26122600-26123200 | Flanking Active TSS | Primary hematopoietic stem cells short term culture | blood |
34 | chr6:26122600-26123200 | Flanking Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
35 | chr6:26122600-26123200 | Flanking Active TSS | Muscle Satellite Cultured Cells | -- |
36 | chr6:26122600-26123200 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
37 | chr6:26122600-26123200 | Flanking Active TSS | Brain Cingulate Gyrus | brain |
38 | chr6:26122600-26123200 | Flanking Active TSS | Fetal Intestine Large | intestine |
39 | chr6:26122600-26123200 | Flanking Active TSS | HSMMtube | muscle |
40 | chr6:26122600-26123200 | Flanking Active TSS | NH-A | brain |
41 | chr6:26122600-26123200 | Flanking Active TSS | Osteobl | bone |
42 | chr6:26122600-26123400 | Flanking Active TSS | Primary T killer memory cells from peripheral blood | blood |
43 | chr6:26122600-26123800 | Active TSS | Brain Germinal Matrix | brain |
44 | chr6:26122600-26124000 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
45 | chr6:26122600-26126800 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
46 | chr6:26122600-26127000 | Active TSS | Brain Angular Gyrus | brain |
47 | chr6:26122600-26127000 | Active TSS | Brain Inferior Temporal Lobe | brain |
48 | chr6:26122600-26127000 | Active TSS | Duodenum Smooth Muscle | Duodenum |
49 | chr6:26122600-26127200 | Active TSS | H9 Cell Line | embryonic stem cell |
50 | chr6:26122600-26127200 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |